Edwin Rock - 02 Sep 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Chief Medical Officer
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
02 Sep 2022
Net transactions value
$0
Form type
4
Filing time
07 Sep 2022, 16:10:14 UTC
Next filing
16 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Employee stock option (right to buy) Award $0 +200,000 $0.000000 200,000 02 Sep 2022 Common Stock 200,000 $0.7400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option will vest on September 2, 2023 and the remaining underlying shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date.